Forte Biosciences, Inc. Common Stock (FBRX) is a publicly traded Healthcare sector company. As of August 27, 2026, FBRX trades at $76.98 with a market cap of $1.63B and a P/E ratio of -16.35. FBRX moved +0.04% today. Year to date, FBRX is +226.09%; over the trailing twelve months it is +583.75%. Its 52-week range spans $4.90 to $77.20. Analyst consensus is neutral with an average price target of $76.60. Rallies surfaces FBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for FBRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $76.98 |
| Market Cap | $1.63B |
| P/E Ratio | -16.35 |
| EPS | $-4.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $77.20 |
| 52-Week Low | $4.90 |
| Volume | 1.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.71M |
| Net Income | $-69.38M |
| Gross Margin | 0.00% |
5 analysts cover FBRX: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $76.60.